| RS1555449314 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1555449461 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS1555449603 |
PMM2
|
Health Risk |
Pathogenic/Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1555449604 |
PMM2
|
Health Risk |
Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1555449607 |
PMM2
|
Health Risk |
Pathogenic/Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1555449617 |
PMM2
|
Health Risk |
Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1555449635 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS1555449642 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1555449780 |
PMM2
|
Health Risk |
Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1555449795 |
PMM2
|
Health Risk |
Conflicting classifications of pathogenicity |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1555449810 |
PMM2
|
Health Risk |
Pathogenic/Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1555449966 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group P |
| RS1555450109 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1555450424 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, Polycystic kidney disease |
| RS1555450475 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1555450487 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS1555450672 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1555450681 |
GNPTG
|
Health Risk |
Pathogenic/Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS1555450716 |
GNPTG
|
Health Risk |
Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS1555450744 |
GNPTG
|
Health Risk |
Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS1555450825 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1555450920 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1555450968 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1555451093 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, Polycystic kidney disease |
| RS1555451101 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS1555451143 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1555451152 |
SPG11
|
Health Risk |
Likely pathogenic |
— |
| RS1555451163 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1555451280 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, Polycystic kidney disease |
| RS1555451368 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1555451417 |
SPG11
|
Health Risk |
Likely pathogenic |
— |
| RS1555451430 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1555451465 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS1555451491 |
SPG11
|
Health Risk |
Pathogenic |
— |
| RS1555451521 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS1555451608 |
GNPTG
|
Health Risk |
Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS1555451643 |
GNPTG
|
Health Risk |
Pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS1555451684 |
GNPTG
|
Health Risk |
Conflicting classifications of pathogenicity |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS1555451866 |
GNPTG
|
Health Risk |
Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS1555451874 |
GNPTG
|
Health Risk |
Pathogenic/Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS1555451983 |
SPG11
|
Health Risk |
Pathogenic |
— |
| RS1555452047 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1555452081 |
GNPTG
|
Health Risk |
Pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS1555452127 |
ALG1
|
Health Risk |
Likely pathogenic |
ALG1-congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS1555452247 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1555452400 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1555452453 |
POLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1555452461 |
POLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1555452510 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1555452572 |
SLC24A5
|
Health Risk |
Pathogenic |
Oculocutaneous albinism type 6, Oculocutaneous albinism type 6 |
| RS1555452574 |
SLC24A5
|
Health Risk |
Pathogenic |
Oculocutaneous albinism type 6, Oculocutaneous albinism type 6 |
| RS1555452607 |
POLG
|
Health Risk |
Pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1555452653 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, Polycystic kidney disease |
| RS1555452738 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1555452849 |
PKD1
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS1555452876 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Elevated circulating creatine kinase concentration, Polycystic kidney disease |
| RS1555452983 |
POLG
|
Health Risk |
Likely pathogenic |
POLG-related disorder, POLG-related disorder |
| RS1555453090 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1555453207 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1555453238 |
PMM2
|
Health Risk |
Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1555453244 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1555453360 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1555453372 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1555453395 |
PKD1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Polycystic kidney disease |
| RS1555453538 |
POLG
|
Health Risk |
Likely pathogenic |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1 |
| RS1555453664 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1555453695 |
ACAN
|
Health Risk |
Pathogenic |
Short stature and advanced bone age, with early-onset osteoarthritis |
| RS1555453708 |
ACAN
|
Health Risk |
Pathogenic |
Short stature and advanced bone age, Short stature and advanced bone age |
| RS1555453727 |
SPG11
|
Health Risk |
Likely pathogenic |
— |
| RS1555453824 |
POLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1555453872 |
PKD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease |
| RS1555453950 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Mitochondrial DNA depletion syndrome 4b |
| RS1555454075 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1555454145 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, Polycystic kidney disease |
| RS1555454318 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1555454339 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Inborn genetic diseases |
| RS1555454353 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1555454373 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1555454411 |
PKD1
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Renal cyst |
| RS1555454460 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant polycystic kidney disease, Polycystic kidney disease |
| RS1555454467 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1555454488 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1555454508 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1555454512 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1555454560 |
ACAN
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555454566 |
NR2E3
|
Health Risk |
Pathogenic/Likely pathogenic |
Enhanced S-cone syndrome, Retinitis pigmentosa 37 |
| RS1555454604 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1555454606 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1555454620 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1555454630 |
ACAN
|
Health Risk |
Pathogenic |
Short stature and advanced bone age, with early-onset osteoarthritis |
| RS1555454739 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1555454847 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic liver disease 1, Polycystic kidney disease |
| RS1555454886 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1555454915 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1555455057 |
ACAN
|
Health Risk |
Pathogenic |
Short stature and advanced bone age, Short stature and advanced bone age |
| RS1555455109 |
PCCA
|
Health Risk |
Likely pathogenic |
— |
| RS1555455127 |
ACAN
|
Health Risk |
Pathogenic |
Short stature and advanced bone age, Short stature and advanced bone age |
| RS1555455246 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1555455266 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1555455279 |
PKD1
|
Health Risk |
Likely pathogenic |
— |